Apyx Medical Corp Share Price Nasdaq
Equities
US03837C1062
Medical Equipment, Supplies & Distribution
Sales 2024 * | 50.01M 3.92B | Sales 2025 * | 54.67M 4.29B | Capitalization | 55.43M 4.35B |
---|---|---|---|---|---|
Net income 2024 * | -26M -2.04B | Net income 2025 * | -24M -1.88B | EV / Sales 2024 * | 1.11 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.01 x |
P/E ratio 2024 * |
-2.13
x | P/E ratio 2025 * |
-2.36
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.08% |
Latest transcript on Apyx Medical Corp
Managers | Title | Age | Since |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 14/12/17 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 12-03 |
Kari Larson
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Waldman
BRD | Director/Board Member | 77 | 14/03/11 |
Craig Swandal
BRD | Director/Board Member | 63 | 08/03/18 |
John Andres
BRD | Director/Board Member | 66 | 16/07/14 |
1st Jan change | Capi. | |
---|---|---|
-4.85% | 179B | |
+4.12% | 113B | |
-3.25% | 67.88B | |
+5.65% | 52.03B | |
+6.04% | 43.3B | |
+4.03% | 41.79B | |
+24.23% | 32.49B | |
+14.00% | 25.65B | |
-3.73% | 24.55B |